A Systemically-Administered Small Molecule Antagonist of CCR9 Acts as a Tissue-Selective Inhibitor of Lymphocyte Trafficking.

Autor: Tubo, Noah J.1,2 (AUTHOR), Wurbel, Marc A.1 (AUTHOR), Charvat, Trevor T.3 (AUTHOR), Schall, Thomas J.3 (AUTHOR), Walters, Matthew J.3 (AUTHOR), Campbell, James J.1,4 (AUTHOR) jcampbell@bwh.rics.harvard.edu
Zdroj: PLoS ONE. Nov2012, Vol. 7 Issue 11, Special section p1-6. 6p.
Databáze: Academic Search Ultimate